Haemochromatosis HCC Surveillance — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — 6-monthly liver ultrasound and AFP for HCC surveillance
Haemochromatosis with established cirrhosis carries a significantly increased risk of hepatocellular carcinoma (HCC) – approximately 20-fold compared to non-cirrhotic haemochromatosis. Even after iron depletion, the HCC risk persists in cirrhotic patients. Six-monthly ultrasound with or without AFP is recommended for HCC surveillance, consistent with general cirrhosis HCC screening guidelines. Non-cirrhotic haemochromatosis patients do not require HCC surveillance.
Reference: eTG – 2025 – Gastrointestinal; EASL – 2010 – Haemochromatosis Guidelines